BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pathology News - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pathologynews.com
X-WR-CALDESC:Events for Pathology News
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260424T080000
DTEND;TZID=America/Los_Angeles:20260424T090000
DTSTAMP:20260826T113653
CREATED:20260323T160016Z
LAST-MODIFIED:20260327T125322Z
UID:100119837-1777017600-1777021200@www.pathologynews.com
SUMMARY:AI Powered QC Where You Need It: Finding Needles in the Haystack
DESCRIPTION:0000Days00Hrs00Min00SecThrough live demonstrations\, and interactive discussions\, attendees will understand the prevalence of artifacts and challenges of manual quality control (QC) for whole slide imaging (WSI). Learn how AI-powered QC helps labs identify the minority of slides with artifacts\, freeing up technician time to focus on the critical few. Innovative\, cutting-edge rescan functionality is designed to fix scanning problems before you know you have them. Aperio iQC software works in tandem with the Aperio GT range of scanners to automatically rescan slides\, with parameters optimized to resolve scan issues\, providing full autonomy\, with the confidence of complete control. Learn how Leica Biosystems’ Aperio iQC software detects artifacts early in the digital pathology workflow\, surfaces results in a centralized dashboard\, alerts the laboratory via the scanner console\, and supports faster\, more consistent quality control. \nLearning Objectives\n\nChallenges and bottlenecks in manual QC\, and how AI-powered QC helps eliminate unnecessary reviews\, and focus only on slides needing attention.\nHow Aperio iQC works in practice\, including the prevalence of artifacts\, where they are detected\, how results appear in the dashboard and scanner console\, and how slides are reviewed and addressed.\nHow to act faster and more consistently on QC findings\, using early artifact visibility to support timely decisions while slides remain in the scanning workflow.\n\nFor Research Use Only. Not for Use in Diagnostic Procedures \nRegister NowSpeakers\nProf. Cleo‑Aron Weis\, MD\, MSc\nHead of Section Computational Pathology\nInstitute of Pathology\, Medical Faculty Heidelberg\, Heidelberg University  \nProf. Cleo‑Aron Weis\, MD\, MSc is a board‑certified pathologist and recognized expert in digital pathology. He brings a unique interdisciplinary background that bridges clinical pathology\, medical physics\, and computational image analysis. His work focuses on morphological tumor heterogeneity\, digital pathology workflows\, and the application of advanced image analysis to improve diagnostic insight and research outcomes. He received his medical degree and Dr. med. from Ruprecht‑Karls‑Universität Heidelberg and holds two Master of Science degrees in Medical Physics\, with a strong emphasis on digital image processing and computational analysis\, including work on HER2/neu classification. Prof. Weis completed his pathology residency and research training at Universitätsmedizin Mannheim and has held senior clinical and academic appointments at both Mannheim and Heidelberg University hospitals. Through his clinical practice and academic research\, Prof. Weis is deeply engaged in advancing the role of digital and computational pathology in modern diagnostics and translational research. \nCatherine Conway\, PhD\nDirector of Clinical AI Applications\nDigital Pathology\, Leica Biosystems  \nDr. Catherine Conway is an accomplished technical leader with more than two decades of experience in Digital Pathology\, Image Analysis/AI\, and Product Development. She has led high impact scientific and technological initiatives across academia\, medical device companies\, and innovative startups\, to advance both research and clinical practice. Her career is distinguished by a strong ability to bridge scientific rigor with practical\, real-world application\, including extensive work in highly regulated environments\, augmented with a strong publication record. Dr. Conway holds a BSc in Biotechnology and a PhD in Digital Pathology from Dublin City University\, Ireland. She later completed a prestigious Postdoctoral Fellowship at the National Cancer Institute (NCI)\, National Institutes of Health (NIH) in the United States. She is deeply committed to translating scientific innovation into impactful tools and workflows that improve patient outcomes and contribute to meaningful medical progress.
URL:https://www.pathologynews.com/event/ai-powered-qc-where-you-need-it-finding-needles-in-the-haystack/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/03/1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260409T150000
DTEND;TZID=Europe/London:20260409T160000
DTSTAMP:20260826T113653
CREATED:20260310T104319Z
LAST-MODIFIED:20260310T154422Z
UID:100119214-1775746800-1775750400@www.pathologynews.com
SUMMARY:From Research to Routine: High-Throughput Spatial Biology with ZEISS and Mindpeak
DESCRIPTION:0000Days00Hrs00Min00SecAs the demand for complex biomarker analysis and precision oncology grows\, organizations face significant hurdles in scaling multiplex immunofluorescence (mIF) and spatial biology for high-throughput production. Traditional spatial workflows are often fragmented\, relying on manual processes and complex image analysis pipelines that require hundreds of hours of training and specialized bioinformatics expertise. \nIn this webinar\, we explore how to eliminate these bottlenecks and transition spatial biology from a low-throughput research tool into a robust\, production-ready environment that delivers images in and results out. We will dive into the integrated\, end-to-end solution developed by ZEISS and Mindpeak\, designed to seamlessly connect reagents\, high-speed scanning\, and automated image analysis. Attendees will learn how the ZEISS AxioScan 7 Spatial Biology enables standardized\, clinical-routine-ready imaging capable of processing up to 100 slides per day. \nFurthermore\, we will demonstrate how Mindpeak’s PhenoScout AI provides a “Turn-key” analysis experience\, allowing users to bypass months of algorithm training and achieve expert-grade\, single-cell precision without requiring any prior image analysis expertise. \nJoin us to discover how this seamless integration minimizes data handling complexities\, accelerates time-to-insight\, and ultimately establishes a reliable pathway from translational research and clinical trials to future diagnostic assays. \nLearning Objectives\n\nIdentify key hurdles of bringing mIF/spatial biology into high-throughput production.\nDiscuss solutions on the reagents\, scanner\, workflow\, and image analysis parts of the workflow\, with an emphasis on PhenoScout by Mindpeak.\nEvaluate the requirements for transitioning from manual research protocols to clinical-routine-ready imaging ecosystems.\n\nWhat We Will Cover\n\nHigh-Throughput Imaging: How the ZEISS AxioScan 7 enables standardized\, clinical-grade imaging for up to 100 slides per day.\nTurn-key AI Analysis: How Mindpeak’s PhenoScout AI provides expert-grade\, single-cell precision without requiring prior image analysis or algorithm training.\nClinical Pathways: How this integration minimizes data handling\, accelerates time-to-insight\, and establishes a reliable path from research to future diagnostic assays.\n\nKey Takeaways\n\nSpatial biology is now ready for production: Organizations can finally scale complex spatial workflows without sacrificing speed or reliability.\nUnlocking Massive Scale and Reliability (ZEISS Advantage): Achieve unprecedented throughput and standardization. By providing a highly reproducible\, clinical-routine-ready imaging ecosystem\, ZEISS allows labs to confidently process up to 100 slides per day\, establishing a clear pathway from translational research to regulatory clearance.\nEliminating the Analysis Bottleneck (Mindpeak Advantage): Experience “Zero Friction” spatial analysis. Mindpeak’s clinically validated AI completely removes the need for specialized bioinformatics expertise or months of software training. Users get immediate\, expert-grade precision\, freeing them to focus entirely on actionable biology rather than managing complex IT infrastructure.\nA Seamless\, End-to-End Clinical Pathway: Together\, ZEISS and Mindpeak deliver a fully automated\, end-to-end solution. From standardized high-quality image acquisition to instant\, reproducible biomarker reporting\, the integrated workflow minimizes data handling complexities and accelerates time-to-insight for high-throughput clients.\nReduced Operational Overhead: Automation of both hardware and software steps significantly lowers the cost-per-slide and reduces human error\, making spatial biology a viable option for large-scale clinical trials.\nStandardization for Future Diagnostics: This integrated approach provides the data consistency and quality control necessary to move biomarkers from the discovery phase toward validated clinical assays.\n\nRegister NowSpeakers\nDr. Moritz Widmaier \nExpert in Spatial Biology & Digital Pathology \nZEISS Research Microscopy Solutions \nDr. Moritz Widmaier is a recognized leader in spatial biology\, digital pathology\, and biomarker data analytics. Currently at ZEISS Research Microscopy Solutions\, he drives innovation in spatial biology workflows\, focusing on automation\, AI-powered image analysis\, and advanced imaging solutions like the ZEISS Axioscan 7 spatial Biology. \nWith a Ph.D. in Biochemistry and a unique ability to bridge the gap between complex biology and data science\, Dr. Widmaier has a proven track record of developing cutting-edge AI and data analytics products. Prior to ZEISS\, he held pivotal scientific and product leadership roles at industry-leading companies\, including Definiens\, AstraZeneca and Ultivue. \nHis extensive expertise spans across (immuno-) oncology\, multiplex immunofluorescence reagent chemistry and assay development and machine learning. Today\, Dr. Widmaier specializes in helping researchers leverage automated imaging and AI to turn intricate spatial data into reproducible\, actionable clinical and research insights. \nDr. Fabian Schneider \nSenior Product Manager \nMindpeak \nFabian Schneider\, PhD\, is Senior Product Manager at Mindpeak\, where he shapes the development and delivery of AI solutions for pathology. He has more than a decade of experience across leading organisations in computational pathology\, oncology and biomarker research. His career has spanned both scientific and product leadership\, from contributing to the establishment of automated data reporting for digital pathology assay data supporting clinical oncology studies at Roche\, to advancing computational pathology pipelines at AstraZeneca and leading product development for research solutions at Visiopharm. \nWith a doctorate from the University Hospital Frankfurt focused on Wnt signalling in tumour formation and angiogenesis\, followed by postdoctoral research at the Karolinska Institutet and the Technical University of Munich\, Dr. Schneider combines scientific depth with hands-on experience in product strategy and clinical translation. At Mindpeak\, he draws on this background to guide the development of AI tools that are scientifically robust\, clinically relevant and aligned with the needs of pathologists worldwide.
URL:https://www.pathologynews.com/event/from-research-to-routine-high-throughput-spatial-biology-with-zeiss-and-mindpeak/
LOCATION:Online
CATEGORIES:Live Online Webinar,PN Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/03/min-web0-assets.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260319T170000
DTEND;TZID=Europe/London:20260319T180000
DTSTAMP:20260826T113653
CREATED:20260205T123809Z
LAST-MODIFIED:20260227T092746Z
UID:100118509-1773939600-1773943200@www.pathologynews.com
SUMMARY:The Cost of Disconnected Systems:  How to Leverage Pathology-Led Integrated Diagnostics on a Single Enterprise Platform
DESCRIPTION:0000Days00Hrs00Min00SecMost health systems are feeling the impact of fragmented diagnostic systems. Digital pathology may be live\, but radiology sits on a separate platform\, molecular data is handled elsewhere\, and AI tools often run as isolated pilots. These disconnects reduce the full potential of digital transformation and make effective collaboration more difficult. They also lead to avoidable delays\, add complexity to MDT meetings\, and increase IT and administrative burden. \nThis session takes a practical look at how digital pathology can anchor an integrated diagnostics strategy on a single enterprise imaging platform. We’ll focus on how leading AMCs and IDNs are approaching this transition\, why organizations are choosing an enterprise framework\, and what benefits they expect as they expand integrated workflows across pathology\, radiology\, and genomics. The discussion will highlight real-world decision-making\, early lessons learned\, and the long-term value of a unified diagnostic platform. \nLearning Objectives:\n\nHow fragmented diagnostic systems affect workflow\, collaboration\, and IT complexity\nWhy digital pathology is well positioned to lead an enterprise imaging strategy across departments\nHow health systems are approaching integrated diagnostics and the expected benefits of a single platform\n\nRegister NowPresenters\nTom Zarzycki \nAccount Manager\, MedicalDirector\, Strategic Development Digital Pathology | ImIT – Applications – Pathology \nJennifer Fralick  \nVice President of Anatomic Pathology and Clinical Laboratories at Stanford Health Care\, where she oversees all Stanford Medicine laboratory operations across the San Francisco Bay Area. In this role\, she has led major strategic initiatives\, including the implementation of two Digital Pathology platforms\, a comprehensive scanner ecosystem\, and Beaker AP. Under her leadership\, Stanford’s pathology and laboratory services expanded significantly to meet rising testing volumes and supported the growing complexity of molecular\, genetic\, and genomic diagnostics. She also played a central role in establishing and scaling Stanford’s COVID‑19 response. \nBefore joining Stanford\, Jennifer built a reputation as a highly regarded program manager at multiple academic medical centers. Her work included leading large‑scale implementations such as Radiology PACS systems\, Epic\, and automated chemistry lines—projects that required deep technical expertise\, operational insight\, and cross‑disciplinary coordination. \nOutside of her professional work\, Jennifer is an avid cyclist and runner. \nJonathan Shoemaker \nJonathan Shoemaker is an accomplished healthcare technology leader with nearly 30 years of experience advancing enterprise imaging\, workflow modernization\, and clinical informatics across major academic medical centers. As Executive Director of Imaging Systems and Services at Stanford Health Care\, he oversees a broad imaging portfolio and led the design of a highly resilient enterprise imaging platform that supports AI\, machine learning\, and real‑time research integration. Recently Mr. Shoemaker’s portfolio architected the latest Digital pathology platform that enables a full dicom deployment and informatics normalization model into Stanford digital pathology. \nPreviously\, at Sutter Health\, Jonathan directed one of the nation’s largest deconstructed PACS implementations\, consolidating 54 medical record systems and migrating 2PB of imaging data while building a new enterprise imaging support organization. His earlier consulting and engineering roles—spanning Ascendian Healthcare Consulting and GE Healthcare—shaped his reputation as a national expert in imaging architecture\, VNA strategy\, workflow optimization\, and complex multi‑system integration. \nRebecca Rojansky  \nDr. Rebecca Rojansky\, MD. PhD. is Associate Director for Clinical Pathology Informatics and Assistant Professor of Pathology at Stanford University School of Medicine. She is a practicing molecular and hematopathologist. Her work focuses on digital and computational pathology\, artificial intelligence\, and clinical informatics infrastructure to enable precision diagnostics.
URL:https://www.pathologynews.com/event/the-cost-of-disconnected-systems-how-to-leverage-pathology-led-integrated-diagnostics-on-a-single-enterprise-platform/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/02/sec-800x6000-updated-time.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251202T140000
DTEND;TZID=Europe/London:20251202T150000
DTSTAMP:20260826T113653
CREATED:20251021T100345Z
LAST-MODIFIED:20251021T100412Z
UID:100116308-1764684000-1764687600@www.pathologynews.com
SUMMARY:Navigating the Future: Implementing Digital Pathology
DESCRIPTION:0000Days00Hrs00Min00SecRegister below! The webinar starts at 2 PM GMT\, 3 PM CET\, and 9 AM EST. \nJoin us for an insightful conversation on what it truly takes to implement a successful\, scalable digital pathology service. \nIn this webinar\, Christopher Parry\, Digital Pathology Sales Specialist at Roche\, and Paul Flavell\, Programme and Portfolio Manager\, draw on their combined expertise in cellular pathology\, cloud migration\, and digital transformation to explore the journey from vision to implementation. \nThrough a presentation and conversational Q&A format\, they’ll unpack the key stages of digital adoption from defining why digitisation matters\, to managing integration\, networking\, and storage requirements\, and overcoming real-world challenges through strong partnerships and collaboration. \nLearning Objectives\n\nWhy a network-wide digital pathology service requires more than just hardware.\nHow strong relationships have driven successful digital pathology deployment.\nWhat benefits are already being realised and what the future holds as AI and algorithmic tools become part of routine diagnosis.\n\nRegister NowPresenters\nChristopher Parry \nWith over 10 years experience within Cellular Pathology\, Chris is now a Digital Pathology Sales Specialist at Roche\, Chris is passionate about leveraging digital pathology and AI to transform cellular pathology. With a focus on driving diagnostic certainty and alleviating the significant backlogs within the field. Background includes roles in tissue diagnostics sales\, as an applications consultant\, and as a biomedical scientist in both the NHS and private sectors. \nPaul Flavell \nPaul is a highly experienced Programme and Portfolio manager\, delivering large complex data center migrations\, cloud migrations and cloud optimisation programmes of work across multiple industries sectors. 5 years with Roche leading teams to design and deliver digital solutions.
URL:https://www.pathologynews.com/event/navigating-the-future-implementing-digital-pathology/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/ROC-WEB0-Featured-image-.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251125T150000
DTEND;TZID=Europe/London:20251125T160000
DTSTAMP:20260826T113653
CREATED:20251106T111722Z
LAST-MODIFIED:20251106T111723Z
UID:100116685-1764082800-1764086400@www.pathologynews.com
SUMMARY:AI in Clinical Digital Pathology: An introduction and live demonstrations of Aperio HALO AP and Aperio AI Store
DESCRIPTION:0000Days00Hrs00Min00SecRegister below! The webinar starts at 4 PM CET\, 3 PM GMT\, and 10 AM EST. \nJoin Leica Biosystems for a dynamic one-hour session exploring how cutting-edge software and artificial intelligence are transforming clinical digital pathology. This webinar will showcase live demonstrations of the Aperio HALO AP Image Management Solution and Aperio AI Store. \n\nBuilding Now for Tomorrow’s Future: Rob Monroe\, MD\, PhD\, VP & Chief Scientific Officer\, Oncology\, Danaher Diagnostics\, Chief Medical Officer\, Leica Biosystems\nIntroduction and Demonstrations for Aperio HALO AP and Aperio AI Store: Bryce Brown\, Director\, Product Management\, Leica Biosystems\nLive Audience Q & A: Linda Fildey\, Senior Manager\, Global Customer Advocacy\, Leica Biosystems (attendees are invited to participate in a live Q&A session with our experts to dive deeper into the technologies and innovations discussed).\n\nWebinar learning objectives:\n\nDiscover how AI tools are empowering pathologists and histotechnologists with advanced tools to enhance diagnostic precision\, streamline workflows\, and support better patient outcomes.\nExplore the capabilities of Aperio HALO AP and Aperio AI Store through live demonstrations\, highlighting practical applications in real-world pathology settings.\nPractical considerations on the importance of building future-ready digital pathology infrastructure\n\nRegister NowPresenters\nRob Monroe\, MD\, PhD\, VP & Chief Scientific Officer\, Oncology\, Danaher Diagnostics\, Chief Medical Officer\, Leica Biosystems \nRob joined Danaher in January 2022 to help drive oncology initiatives for the Diagnostics Platform and lead Medical Affairs at Leica Biosystems. Over the course of his career\, Rob has served in multiple Chief Medical Officer and Medical Director roles for diagnostics companies including Bio-Techne\, Advanced Cell Diagnostics\, Veracyte\, and BioImagene. Before joining industry\, Rob practiced pathology in the Central Coast of California following residency/fellowship training in Pathology at UCLA and Stanford and MD/PhD training at Harvard Medical School. \nBryce Brown\, Director\, Product Management\, Leica Biosystems \nBryce Brown is an accomplished leader in digital pathology and molecular diagnostics\, currently serving as Director of Product Management\, Digital Pathology at Leica Biosystems. With over a decade of experience at Leica Biosystems\, Bryce has held multiple strategic roles\, including leadership in Artificial Intelligence and Machine Learning\, where he helped shape product innovation across remote teams in the U.S.. Bryce has also worked as a Cytogenetic Hematological Chromosome Technologist at the Mayo Clinic\, where he contributed to high-impact clinical diagnostics in hematological disorders. He holds a Bachelor of Science in Cellular and Molecular Biology from Winona State University. \nLinda Fildey\nSenior Manager\, Global Customer Advocacy\nLeica Biosystems
URL:https://www.pathologynews.com/event/ai-in-clinical-digital-pathology-an-introduction-and-live-demonstrations-of-aperio-halo-ap-and-aperio-ai-store/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/11/FINAL-LSB-WEB8-800X600.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251120T160000
DTEND;TZID=Europe/London:20251120T170000
DTSTAMP:20260826T113654
CREATED:20251009T090234Z
LAST-MODIFIED:20251009T090234Z
UID:100115983-1763654400-1763658000@www.pathologynews.com
SUMMARY:HistoWiz x PathologyOutlines: Seamless Digital Slide Integration with PathologyMap™
DESCRIPTION:0000Days00Hrs00Min00SecJoin HistoWiz and PathologyOutlines.com for an inside look at how their new partnership is transforming digital pathology publishing. This webinar will showcase how PathologyMap™\, HistoWiz’s secure digital slide management platform\, now integrates with PathologyOutlines.com to make research articles more interactive and accessible. Attendees will see firsthand how authors can easily upload digital slides\, embed high-resolution images directly into articles\, and provide readers with frictionless access to pathology content. Learn how this collaboration is setting a new standard for open-access education and discover tools that simplify workflows for authors\, readers\, and the pathology community at large. \nLearning Objectives\n\nUnderstand how PathologyMap™ integrates with PathologyOutlines.com to simplify digital slide sharing and publishing.\nIdentify the benefits of embedding interactive whole slide images within research articles for both authors and readers.\nExplore how this collaboration supports open-access education and democratizes access to pathology data worldwide.\nRecognize opportunities to adopt digital pathology tools that enhance learning\, research dissemination\, and clinical insights.\n\nRegister NowSpeakers\nAkash Parvatikar\, PhD \nAI Scientist and Product Manager\, HistoWiz \nKristi Marie \nManaging Editor\, PathologyOutlines.com
URL:https://www.pathologynews.com/event/histowiz-x-pathologyoutlines-seamless-digital-slide-integration-with-pathologymap/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/Histowiz-webinar-featured-image.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251113T160000
DTEND;TZID=Europe/London:20251113T170000
DTSTAMP:20260826T113654
CREATED:20251013T142900Z
LAST-MODIFIED:20251022T123244Z
UID:100116156-1763049600-1763053200@www.pathologynews.com
SUMMARY:Mastering Image Quality Control with AIRA Matrix
DESCRIPTION:0000Days00Hrs00Min00SecRegister below! The webinar starts at 5 PM CET\, 4 PM GMT\, and 11 AM EST. \nArtificial intelligence is transforming how laboratories and life science organizations approach quality control. This webinar will answer the key question: Why address quality control issues with AI? We’ll explore the benefits of AI-driven solutions\, highlight differentiating features\, and provide a live product demonstration to show how Aira Matrix can improve efficiency and consistency in lab workflows. Attendees will gain practical insights into how AI can help reduce errors\, streamline processes\, and support more reliable outcomes. \nThe session will be led by Marco Comianos\, who heads Aira Matrix’s commercial organization in the United States and Canada. With over 25 years of experience in sales\, marketing\, and commercial leadership across healthcare and life sciences—including roles in medical imaging\, EMR\, and healthcare AI—Marco brings deep expertise in aligning innovative technologies with real-world clinical and research needs. \nLearning Objectives\n\nWhy addressing quality control with AI matters\nHow Aira Matrix differentiates itself in the market\nKey product features and their impact on efficiency\nA live demo of the platform in action\n\nRegister NowPresenter\nMarco Comianos heads Aira Matrix’s commercial organization in the United States and Canada.  He has over 25 years of experience in sales\, marketing and commercial leadership in the Healthcare and Life Sciences industries\, at a broad range of medical imaging\, EMR and healthcare AI companies. He holds a Bachelor of Science Degree in Business Administration
URL:https://www.pathologynews.com/event/mastering-image-quality-control-with-aira-matrix-2/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/AIM-WEB0-Featured-Image.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20251015T150000
DTEND;TZID=Europe/Paris:20251015T160000
DTSTAMP:20260826T113654
CREATED:20250902T135514Z
LAST-MODIFIED:20251013T141041Z
UID:100115332-1760540400-1760544000@www.pathologynews.com
SUMMARY:Spatially Resolved Transcriptomics and Graph-based Deep Learning Improve Accuracy of Routine CNS Tumor Diagnostics
DESCRIPTION:0000Days00Hrs00Min00SecRegister below! The webinar starts at 3 PM CET\, 2 PM BST\, and 9 AM EST. \nSpatially resolved transcriptomics and graph-based deep learning are transforming how researchers approach and understand central nervous system (CNS) tumors. In this webinar we will deep dive into a publication that highlights how the NePSTA (neuropathology spatial transcriptomic analysis) framework combines advanced RNA sequencing technologies with neural network analyses to uncover detailed gene expression landscapes directly within tissue samples—even in complex or ambiguous cases. By mapping gene activity across individual tumor regions\, these tools reveal previously hidden molecular characteristics\, allow for more granular tissue classification\, and address challenges posed by compromised sample quality. \nLearning Objectives:\n\nUnderstand the challenges of conventional CNS tumor diagnostics and how spatial transcriptomics addresses them.\nLearn the basics of spatially resolved transcriptomics and how graph-based deep learning is applied in neuropathology.\nCompare spatial transcriptomics with traditional molecular techniques such as DNA methylation profiling and next-generation sequencing.\n\nRegister NowSpeaker:\nProf. Felix Sahm \nProf. Dr. Dr. med. Felix Sahm\, MBA is Vice-Chair of the Department of Neuropathology and Head of Molecular Neuropathology \nUniversity of Heidelberg \nAn internationally recognized expert in brain tumor diagnostics\, he has authored over 500 publications\, including landmark studies shaping the WHO classification of CNS tumors. His research focuses on integrating molecular and multi-omic approaches to improve precision diagnostics and patient care.
URL:https://www.pathologynews.com/event/spatially-resolved-transcriptomics-and-graph-based-deep-learning-improve-accuracy-of-routine-cns-tumor-diagnostics/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/09/GEN-WEB0-Featured-Image.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251001T150000
DTEND;TZID=Europe/London:20251001T160000
DTSTAMP:20260826T113654
CREATED:20250822T130516Z
LAST-MODIFIED:20250919T113346Z
UID:100115222-1759330800-1759334400@www.pathologynews.com
SUMMARY:Adapt or Fall Behind: Why the Best Labs Use AI
DESCRIPTION:0000Days00Hrs00Min00SecArtificial intelligence is reshaping the lab landscape—not in the future\, but now. In this webinar\, we’ll explore why adopting AI is no longer optional for modern labs and share real-world insights from clinical leaders who have already taken the leap. Learn how labs in anatomic pathology\, microbiology\, cytology\, and more are using AI to impact their staff and the patients they serve—and the lessons they’ve learned along the way. \nPresenter\n\nDr. Chen is a leader in digital and computational pathology\, holding a medical degree from the Mayo Clinic Alix School of Medicine and a master’s in Global Medicine from USC. She completed her anatomic pathology residency at Brigham and Women’s Hospital and an NIH/NCI postdoctoral fellowship in computational pathology at Harvard Medical School and Mass General Brigham. Before joining Techcyte\, Dr. Chen led digital pathology initiatives at a cancer pharmaceutical company\, driving advancements in AI-powered diagnostics.\n\n\n\nRegister Now
URL:https://www.pathologynews.com/event/adapt-or-fall-behind-why-the-best-labs-use-ai/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/WhatsApp-Image-2025-08-22-at-12.34.19-PM.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20250925T170000
DTEND;TZID=Europe/London:20250925T180000
DTSTAMP:20260826T113654
CREATED:20250520T203901Z
LAST-MODIFIED:20250919T113423Z
UID:100112612-1758819600-1758823200@www.pathologynews.com
SUMMARY:Prognostic Risk Profiling from Digitized H&E: a look at new international performances of an AI model for breast cancer
DESCRIPTION:0000Days00Hrs00Min00SecRegister using the link\, available below! \nJoin expert pathologist\, Magali Lacroix-Triki\, and Owkin senior data scientist\, Valentin Guary\, as they present new findings on RlapsRisk® BC\, an innovative AI-driven solution for breast cancer recurrence risk assessment from digital pathology slides. This webinar will showcase comprehensive data comparing RlapsRisk® BC’s performance against traditional clinical scores and established molecular tests. Our panel will discuss how this revolutionary tool helps to enhance prognostic accuracy and has the potential to transform treatment decision-making in breast cancer care. \nAttendees will gain valuable insights into:\n▪ The impact of AI-powered digital pathology solutions for outcome and prognostic prediction\n▪ Latest performance results from ongoing studies\n▪ First comparisons with current testing approaches\n▪ Real-world implementation experiences\n▪ Potential impact on treatment planning and patient care \nRlapsRisk® BC is under development and not for clinical use. It is not FDA cleared or approved in the USA. RlapsRisk® BC is developed within the PortrAIt consortium\, a french consortium financed by the government within the framework of France 2030 and by the European Union – Next Generation EU within the framework of the France Relance Plan. \nRegister Here
URL:https://www.pathologynews.com/event/prognostic-risk-profiling-from-digitized-he-a-look-at-new-international-performances-of-an-ai-model-for-breast-cancer/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/gif:https://www.pathologynews.com/wp-content/uploads/2025/05/Featured-Image-Breast-Cancer-Recurrence-Risk-Assessment-from-Digitized-HE-with-RlapsRisk-BC-a-Clinically-Validated-AI-Prognostic-Solution.gif
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250917T150000
DTEND;TZID=UTC:20250917T160000
DTSTAMP:20260826T113654
CREATED:20250818T110738Z
LAST-MODIFIED:20250919T113433Z
UID:100115115-1758121200-1758124800@www.pathologynews.com
SUMMARY:Future-ready Pathology: Embracing digital transformation for improved patient care
DESCRIPTION:0000Days00Hrs00Min00SecRegister using the link\, available below! \nTwo leading European hospital networks—Hospital Universitario Quirónsalud Madrid and Groupe Hospitalier Paris Saint-Joseph/Hôpital Marie-Lannelongue—shared how they transformed pathology services through digital innovation in collaboration with Philips. The webinar highlights how cloud infrastructure enables scalable\, compliant storage; AI enhances diagnostic speed and quality; and integrated diagnostics are bringing pathology and radiology together for more connected\, patient-centered care. \nLearning Objectives:\n\nUnderstand how digital pathology enables subspecialty-based collaboration across hospitals\, enhancing diagnostic quality and operational flexibility.\nExplore how AI tools support lesion detection and quantification to improve diagnostic efficiency and accuracy.\nLearn how end-to-end support from Philips—including infrastructure planning and cloud integration—facilitates scalable digital transformation.\nRecognize the role of cloud-based storage and intelligent retention policies in streamlining data management and enabling integrated diagnostics.\n\nREGISTER HERE
URL:https://www.pathologynews.com/event/future-ready-pathology-embracing-digital-transformation-for-improved-patient-care/
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/PHI-WEB0-Featured-Image.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20250909T160000
DTEND;TZID=Europe/London:20250909T170000
DTSTAMP:20260826T113654
CREATED:20250822T135627Z
LAST-MODIFIED:20250919T113511Z
UID:100115229-1757433600-1757437200@www.pathologynews.com
SUMMARY:Mastering Image Quality Control with AIRA Matrix
DESCRIPTION:Artificial intelligence is transforming how laboratories and life science organizations approach quality control. This webinar will answer the key question: Why address quality control issues with AI? We’ll explore the benefits of AI-driven solutions\, highlight differentiating features\, and provide a live product demonstration to show how Aira Matrix can improve efficiency and consistency in lab workflows. Attendees will gain practical insights into how AI can help reduce errors\, streamline processes\, and support more reliable outcomes. \nThe session will be led by Marco Comianos\, who heads Aira Matrix’s commercial organization in the United States and Canada. With over 25 years of experience in sales\, marketing\, and commercial leadership across healthcare and life sciences\, including roles in medical imaging\, EMR\, and healthcare AI. Marco brings deep expertise in aligning innovative technologies with real-world clinical and research needs. \nLearning Objectives\n\nWhy addressing quality control with AI matters\nHow Aira Matrix differentiates itself in the market\nKey product features and their impact on efficiency\nA live demo of the platform in action\n\nRegister Now
URL:https://www.pathologynews.com/event/mastering-image-quality-control-with-aira-matrix/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/AIM-WEB0-Featured-Image.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250709T150000
DTEND;TZID=UTC:20250709T160000
DTSTAMP:20260826T113654
CREATED:20250707T081413Z
LAST-MODIFIED:20250919T113526Z
UID:100114127-1752073200-1752076800@www.pathologynews.com
SUMMARY:Histolog Scanner Confocal Microscopy: Pathology Image Evaluation of Surgical Margins in Robot Assisted Radical Prostatectomies
DESCRIPTION:0000Days00Hrs00Min00SecRegister using the link below \nEvaluation of Histolog Scanner images by pathologists has been shown to demonstrate high accuracy in surgical margin assessment. Learn how to evaluate Histolog Scanner images in RARP. \nLearning objectives\n\nUnderstand the value of intraoperative margin assessment in RARP\nIntroduction to Histolog images evaluation for prostate surgical margins\nEducate pathologist and surgeon in analyzing Histolog image and their correlation to H&E – comparative examples\n\nRegister Here
URL:https://www.pathologynews.com/event/histolog-scanner-confocal-microscopy-pathology-image-evaluation-of-surgical-margins-in-robot-assisted-radical-prostatectomies/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/07/featured.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20250618T180000
DTEND;TZID=Europe/London:20250618T190000
DTSTAMP:20260826T113654
CREATED:20250520T234748Z
LAST-MODIFIED:20250919T113539Z
UID:100112620-1750269600-1750273200@www.pathologynews.com
SUMMARY:Enhancing Flexibility and Performance with the Latest Aperio GT 450 Updates
DESCRIPTION:0000Days00Hrs00Min00SecRegister using the link below \nRecent updates to the Aperio GT 450 introduce exciting new capabilities\, including scanning at 20x\, z-stack acquisition\, and manual scanning options for challenging slides. These enhancements bring even greater flexibility to the Aperio GT 450 platform\, building on its well-established speed and throughput advantages. \nCharles River Laboratories\, a long-time user of the Aperio AT2 with over a dozen units in operation at peak use\, had previously relied on manual scanning capabilities for certain complex tissue types such as bone marrow\, ocular tissue\, small samples\, and cell lines. The new Aperio GT 450 enhancements offer a bridge between the flexibility of the Aperio AT2 and the high-speed automation of the Aperio GT 450\, giving laboratories even more tools to meet diverse scanning needs. \nAs a beta site for the enhanced features\, Charles River Laboratories evaluated the latest Aperio GT 450 functionality and found the manual scanning capabilities particularly impactful. Based on their positive experience\, they are now moving forward with upgrading their entire Aperio AT2 fleet to the enhanced Aperio GT 450 platform. \nIn this presentation\, we’ll deepen your understanding of the Aperio GT 450 and explore real-world examples of the updated manual scanning features compared with legacy Aperio AT2 scans. We’ll also share strategies for optimizing lab workflows for digital pathology\, offer practical tips for scanning\, especially with difficult tissue types\, and discuss the broader value of going digital. \nLearning Objectives:\n\nDeepen understanding of the Aperio GT 450 platform and its enhanced features\nLearn how to optimize your lab for scanning success—workflow\, lab design & slide preparation\nUnderstand how slide prep quality impacts downstream imaging\nExplore tips and techniques for scanning difficult tissues\nDiscuss the benefits and opportunities of digital pathology\n\nFor research use only. Not for use in diagnostic procedures. \nRegister HerePresenters\nSarah O’Connor \nSarah O’Connor has almost 10 years of experience in digital pathology and has utilized multiple scanning platforms. As a Digital Pathology Implementation and Training Specialist with Charles River Laboratories\, Sarah has supports Charles River’s efforts to further their digital delivery through product testing and validation of new scanners and digital pathology software. \nCharles River’s digital pathology process is fully validated for GLP primary evaluation and peer review use. During her tenure as a Tissue Cross Reactivity Research Assistant Sarah gained extensive experience with hard to scan tissue such as cell lines\, protein spots\, and faintly stained tissues. When not focused on digital pathology\, Sarah likes to spend her time hiking and fly fishing with her dog Beowulf. \nDiane Robirds \nDiane Robirds joined Leica Biosystems in 2015 and has worked in Digital Pathology sales\, training\, and application support roles.  Before joining Leica Biosystems\, she spent many years in Genomics and Pathology laboratories\, both clinical and research\, from the bench to lab management. \nIn her current role as National Workflow and Solution Architect for Life Sciences\, she enjoys getting to know each laboratory’s unique goals and needs on their Digital Pathology journey- to provide guidance in implementation\, workflow customization\, in-depth training and ongoing support.  Outside of work\, Diane enjoys traveling with her husband\, playing the piano\, and spending time with family.
URL:https://www.pathologynews.com/event/enhancing-flexibility-and-performance-with-the-latest-aperio-gt-450-updates/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/05/Featured-Image-Faster-Smarter-Scanning-Unlocking-the-Full-Potential-of-the-Aperio-GT-450-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20250603T210000
DTEND;TZID=Europe/Paris:20250603T220000
DTSTAMP:20260826T113654
CREATED:20250512T134059Z
LAST-MODIFIED:20250919T113557Z
UID:100111813-1748984400-1748988000@www.pathologynews.com
SUMMARY:What Pathologists Really Want: Global Insights into the Future of Digital Pathology
DESCRIPTION:0000Days00Hrs00Min00SecRegister using the form or link\, available below! Find your panellists further down. \nSummary\nAfter traveling across continents and speaking with hundreds of pathologists at conferences and institutions worldwide\, Chelsea Sowards and James Thackeray have heard it all—frustrations\, hopes\, hesitations\, and wish lists. This webinar goes beyond hype and buzzwords to uncover what pathologists are actually looking for in a digital pathology solution—and why so many current options miss the mark. \nJoin us for a candid conversation that distills global feedback into five core needs pathologists consistently voice\, followed by a discussion of how Lumea is delivering on each one. If you’re looking to cut through the noise and find a practical\, pathologist-centered approach to digital transformation\, this is the session for you. \nWebinar learning objectives:\n\nHear firsthand insights from global pathology conferences and institutions about the current state of digital pathology adoption.\nIdentify the top five features and outcomes pathologists consistently seek in a digital pathology solution.\nUnderstand the gap between industry offerings and real-world needs in pathology workflows.\nDiscover how Lumea is meeting those needs with innovation\, integration\, and clinical relevance.\nGain talking points and criteria to evaluate digital pathology solutions with confidence.\n\nRegister Now
URL:https://www.pathologynews.com/event/what-pathologists-really-want-global-insights-into-the-future-of-digital-pathology/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/05/New-Featured-Image-LUM-WEB0.jpg
END:VEVENT
END:VCALENDAR